- A research team has revealed that a molecule in the brain — ophthalmic acid — unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson's and other movement diseases.
- Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor impulse control. Now, researchers have identified a structure in the brain called the external globus pallidus which may be responsible for this side effect, paving the way for new treatments.
- A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.
- A research team has developed an analysis pipeline to identify unexploited genes for a given disease against five databases that provide gene-disease associations. They used their pipeline to study oxidative stress and its related disease, Parkinson's disease, as a case study.
- A finding by neuroscientists could open doors to new treatments for a range of psychiatric and neurological disorders attributed to dysfunctions in specific dopamine pathways.
- Contrary to previous research, a new study of female participants finds no link between migraine and the risk of developing Parkinson's disease.
- An enzyme called PGK1 has an unexpectedly critical role in the production of chemical energy in brain cells, according to a preclinical study. The investigators found that boosting its activity may help the brain resist the energy deficits that can lead to Parkinson's disease.
- Two new studies are pointing the way toward round-the-clock personalized care for people with Parkinson's disease through an implanted device that can treat movement problems during the day and insomnia at night.
- Using machine learning to analyze video recordings of individuals performing simple movements, researchers developed a method to automaticaly quanitfy motor systems in early-stage Parkinson's disease and other movement disorders.
- A research team examined the effect of Ecklonia cava polyphenols on the prevention of Parkinson's disease. It was found that the oral intake of the seaweed antioxidants restores motor function and protects dopaminergic neurons in model mice, while cellular experiments revealed the biochemical interaction of their preventive effect.
- New research suggests that two proteins, amyloid- and phosphorylated tau, the key proteins of Alzheimer's disease, are detected in blood once symptoms have started in Lewy's body diseases, such as Parkinson's. They also found that monitoring the neurofilament light chain protein can detect Lewy body diseases prior to symptom development. The findings suggest a means […]
- An automated assessment technique that uses artificial intelligence could revolutionize the management of Parkinson's disease.